32^nd World Congress of the World Society of Cardiovascular and Thoracic Surgeons in Barcelona, 5.-7. September 2024

Dr. Sarikouch is going to present “Long-term results of modern homografts” within the session "Cardiovascular Tissue Banking at the WSCTS in Barcelona, ”. Decellularized pulmonary and aortic homografts have been studied in prospective European-wide multi-center settings.

https://academic.oup.com/ejcts/article/62/5/ezac219/6568944

https://academic.oup.com/ejcts/article/65/4/ezae121/7635581

EACTS 2^nd Innovation Summit, 18-20. April 2024, Paris

The 2^nd EACTS Innovation Summit was held at the Chateau Les Pres d`Ecoublay near Paris this April. Sessions were dedicated to the “Future of Robotic Surgery”, “Extracorporal Circulation”, “Artificial Intelligence for Cardiothoracic Surgery” and the “Heart valve of the future”

https://www.eacts.org/our-community/news-hub/eacts-hosts-paris-innovation-summit/

Update on double semilunar valve replacement with decellularized homografts

Patients with congenital heart disease frequently require surgical or percutaneous interventional valve replacement after initial congenital heart defect (CHD) repair. In some of these patients, simultaneous replacement of both semilunar valves is necessary, resulting in increased procedural complexity, morbidity, and mortality. In this study, we analyze the outcomes of simultaneous aortic and pulmonary valve replacements following multiple surgical interventions for CHD.

This study study focuses on the evaluation of our surgical experience and follow-up results after combined aortic and pulmonary valve replacement using different valve types.

https://www.thieme-connect.com/products/ejournals/abstract/10.1055/a-2041-3528

This project has received funding from the European Union’s Seventh Framework Programme (FP7/2007-20013) under Grant Agreement Number 278453.

ClinicalTrials.gov identifier: NCT02035540